1529-0131/asset/olbannerleft.gif?v=1&s=897b81612b4ad6cae003112184adc709261d5f61)
1529-0131/asset/olbannerright.gif?v=1&s=04654f5ea3cbb01656383e0c0d04b16fd0a9a896)
Research Article
You have full text access to this OnlineOpen article
Dialysis-associated systemic fibrosis (nephrogenic fibrosing dermopathy): Study of inflammatory cells and transforming growth factor β1 expression in affected skin
Article first published online: 5 AUG 2004
DOI: 10.1002/art.20362
Copyright © 2004 by the American College of Rheumatology
1529-0131/asset/cover.gif?v=1&s=104d5c2bb8ef72deba26790b855af7ab80697a0e "Arthritis & Rheumatism")
Additional Information
How to Cite
Jiménez, S. A., Artlett, C. M., Sandorfi, N., Derk, C., Latinis, K., Sawaya, H., Haddad, R. and Shanahan, J. C. (2004), Dialysis-associated systemic fibrosis (nephrogenic fibrosing dermopathy): Study of inflammatory cells and transforming growth factor β1 expression in affected skin. Arthritis & Rheumatism, 50: 2660–2666. doi: 10.1002/art.20362
Publication History
- Issue published online: 5 AUG 2004
- Article first published online: 5 AUG 2004
- Manuscript Accepted: 1 APR 2004
- Manuscript Received: 7 NOV 2003
Funded by
- NIH. Grant Number: AR-19161
REFERENCES
- 1, , , , , . Scleromyxoedema-like cutaneous disease in renal-dialysis patients. Lancet 2000; 356: 1000–1.
- 2, , , , . Nephrogenic fibrosing dermopathy. Am J Dermatopathol 200l; 23: 383–93.
- 3. Nephrogenic fibrosing dermopathy: the first 6 years. Curr Opin Rheumatol 2003; 15: 785–90.
- 4, , , , . Nephrogenic fibrosing dermopathy: a novel cutaneous fibrosing disorder in patients with renal failure. Am J Med 2003; 114: 563–72.
- 5, , , . Nephrogenic fibrosing dermopathy with systemic involvement. Arch Dermatol 2003; 139: 903–6.
- 6. Scleroderma. In: Modern medical monographs. New York: Grune & Stratton; 1966. p. 81.
- 7, . Pulmonary vascular changes in scleroderma. Am J Med 1978; 64: 998–1004.
- 8, , , . Cell death: a trigger of autoimmunity? Bioessays 2000; 22: 627–36.Direct Link:
- 9, . Expression of transforming growth factor type β on human epidermal dendritic cells. J Invest Dermatol 1992; 99: 114–6.
- 10, . TGF-β1 regulation of dendritic cells. Microbes Infect 1999; 1: 1283–90.
- 11, , , , , . Transforming growth factor β1, in the presence of granulocyte/macrophage colony-stimulating factor and interleukin 4, induces differentiation of human peripheral blood monocytes into dendritic Langerhans cells. J Exp Med 1998; 187: 961–6.